Related Experiment Videos
[Instability of the detrusor. Treatment with oxybutynin chloride (Ditropan) in children]
J Vallejo Herrador1, J M Rodríguez Luna, A Fernández Fernández
1Servicio de Urología, Hospital Ramón y Cajal, Universidad de Alcalá de Henares, Madrid.
Insights
Oxybutynin chloride (Ditropan) significantly improved clinical symptoms and urodynamic findings in children with bladder instability. Long-term treatment demonstrated sustained benefits and good tolerance in pediatric patients.
Area of Science:
- Pediatric Urology
- Pharmacology
- Urodynamics
Context:
- Vesical instability affects children, leading to clinical and urodynamic abnormalities.
- Diagnosis relies on both clinical presentation and urodynamic assessment.
- Oxybutynin chloride is a potential treatment option for pediatric bladder dysfunction.
Purpose:
- To evaluate the efficacy and safety of oxybutynin chloride in children with vesical instability.
- To assess the impact of long-term treatment with oxybutynin chloride.
- To correlate clinical improvement with urodynamic changes.
Summary:
- A study of 24 children (ages 5-14) with diagnosed vesical instability was conducted.
- Patients received oxybutynin chloride treatment for 10-36 months (average 20 months).
- Overall clinical improvement was observed in 87.5% and urodynamic improvement in 83.3% of patients.
Impact:
- Oxybutynin chloride demonstrates significant clinical and urodynamic benefits in pediatric patients with bladder instability.
- Prolonged treatment with oxybutynin chloride is associated with sustained efficacy.
- The medication exhibits good tolerance in the pediatric population, supporting its use in managing vesical instability.
Abstract:
We study the effect of oxybutynin chloride (Ditropan) in a random sample of 24 children with ages ranging from 5 to 14 years, diagnosed as having vesical instability from both the clinical and urodynamic standpoints. These effects were evaluated after a period of treatment that ranged from 10 to 36 months (x = 20). We obtained overall clinical improvement in 87.5%, and improvement of urodynamic alterations in 83.3% of the patients. We single out the beneficial effect of oxybutynin chloride with prolonged treatments, in instability of the detrusor, as well as its good tolerance.